Digital diabetes management platforms — the software ecosystems integrating CGM data, insulin delivery records, activity tracking, dietary logging, and clinical decision support into comprehensive diabetes management — represent the fastest-growing commercial dimension of the US insulin delivery market, with the US Insulin Delivery Devices Market reflecting digital integration as a value-adding market segment.

Glooko and Tidepool diabetes data platforms — the diabetes data aggregation platforms collecting data from CGMs, insulin pumps, smart pens, and blood glucose meters into unified longitudinal diabetes datasets — create the digital health infrastructure supporting clinical decision-making. Glooko's platform integrating with over two hundred diabetes devices and Tidepool's open-source commitment creating the data infrastructure that endocrinology practices use for remote patient monitoring and AID algorithm development.

Telemedicine diabetes management expansion — the COVID-19-accelerated and post-pandemic-sustained telemedicine diabetes care enabling endocrinologists and diabetes educators to manage patients remotely using device-transmitted data — creates the digital health delivery model that increases the value of connected insulin delivery devices. Telemedicine diabetes visits requiring patients to upload CGM and insulin delivery data before appointments creating the implicit requirement for connected insulin delivery devices that transmit usable data.

Predictive analytics and AI in insulin dosing — the emerging AI-powered dosing recommendation systems analyzing historical glucose patterns, insulin response, activity, and dietary patterns to provide predictive insulin dosing guidance — represent the next frontier of digital diabetes support. Medtronic Sugar.IQ (now integrated into MiniMed systems), Sanofi's digital health programs, and academic AI dosing programs demonstrate the commercial development of AI-assisted insulin delivery.

Do you think AI-powered insulin dosing guidance will eventually replace endocrinologist-directed pump programming adjustments for the majority of stable insulin pump users?

FAQ

What digital health platforms integrate with US insulin delivery devices? US digital diabetes platforms: Tidepool — open-source platform; AID algorithm development (Tidepool Loop); pump and CGM data integration; clinical portal; Glooko — commercial platform; over two hundred device integrations; clinic reporting; population health; LibreView (Abbott) — Libre CGM data management; clinic and patient portals; Dexcom Clarity — G6/G7 data reporting; HCP and patient access; t:connect (Tandem) — pump and CGM data; remote monitoring; InPen app (Medtronic) — smart pen data; IOB tracking; CGM integration; regulatory: FDA oversight of medical software; clinical decision support software distinction; prescription digital therapeutics pathway.

How is remote patient monitoring being used for insulin delivery management? RPM insulin delivery applications: CPT codes for remote physiological monitoring (CPT 99453-99458); reimbursable under Medicare and most commercial insurance; automated CGM data alerts enabling proactive clinical intervention; monthly data review replacing quarterly in-office HbA1c-only visits; improved outcomes demonstrated in T1D RPM programs; reducing emergency visits from severe hypoglycemia; insulin delivery data transmission essential for meaningful RPM; commercial opportunity — RPM programs creating recurring service revenue for endocrinology practices; device manufacturers providing RPM data platforms as value-added services supporting device adoption.

#USInsulinDelivery #DigitalDiabetes #DiabetesTelemedicine #TidepoolDiabetes #GlookoPlatform #ConnectedInsulin